NCT02249169View on ClinicalTrials.gov

Developing Novel Microbiota-Targeted Therapies for Irritable Bowel Syndrome

CompletedOBSERVATIONAL

Enrollment

84

Participants

Timeline

Start Date

September 19, 2014

Primary Completion Date

February 8, 2017

Study Completion Date

February 8, 2017

Conditions

Irritable Bowel Syndrome

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

University of Minnesota

OTHER

lead

Mayo Clinic

OTHER